Capital World Investors
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1422849
LOS ANGELES, CA
Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$11,327,882,090
-$237,414,021 QoQ
Shares Held
25,368,124
-0.6% QoQ
Ownership
10.00%
of shares outstanding
% of Portfolio
1.58%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.85723027843919.ToString("F0")%
Shared 0.ToString("F0")%
None 0.142769721560806.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Capital World Investors holds $23,534,298,325 across 32 Biotechnology names. VRTX ranks #1 (48.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
25,368,124 | $11,327,882,090 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,802,348 | $3,574,172,882 | |
| 3 | ARGX |
Argenx SE
|
2,256,216 | $1,647,601,734 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
21,186,369 | $1,590,884,448 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,419,000 | $1,096,376,160 | |
| 6 | MRNA |
Moderna, Inc.
|
18,697,694 | $949,842,855 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
2,673,376 | $505,401,732 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
1,622,687 | $481,889,358 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,327,882,090 | 25,368,124 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $11,565,296,111 | 25,510,182 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $10,147,622,292 | 25,910,587 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $12,791,550,063 | 28,732,143 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $13,833,518,384 | 28,533,308 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $11,406,757,376 | 28,325,695 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $12,469,121,286 | 26,810,702 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $12,518,557,823 | 26,707,966 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,687,338,583 | 25,567,184 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $8,872,549,755 | 21,805,770 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,252,944,882 | 17,981,667 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,102,342,510 | 17,340,634 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,086,623,354 | 16,144,423 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,687,433,552 | 12,769,006 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,626,395,557 | 12,524,679 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,542,081,138 | 12,569,932 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,305,479,946 | 12,666,130 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $2,529,979,758 | 11,520,855 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,002,963,159 | 11,042,302 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,221,030,666 | 11,015,378 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,075,294,802 | 9,657,475 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,281,662,992 | 9,654,155 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,091,423,341 | 11,360,515 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,625,461,825 | 12,488,243 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,993,343,898 | 12,579,718 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||